AI
QNTM

AdvisorShares Investments’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

AdvisorShares Investments’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$524K Buy
108,591
+58,958
+119% +$266K 0.1% 123
2025
Q4 		$362K Buy
49,633
+12,396
+33% +$135K 0.06% 204
2025
Q3 		$611K Buy
37,237
+247
+0.7% +$4.88K 0.1% 102
2025
Q2 		$749K Sell
36,990
-12,000
-24% -$148K 0.14% 83
2025
Q1 		$391K Sell
48,990
-20,088
-29% -$115K 0.08% 185
2024
Q4 		$254K Buy
69,078
+42,845
+163% +$202K 0.05% 209
2024
Q3 		$105K Buy
26,233
+17,692
+207% +$110K 0.02% 250
2024
Q2 		$75.5K Buy
8,541
+1,990
+30% +$48.5K 0.01% 259
2024
Q1 		$305K Buy
6,551
+2,392
+58% +$131K 0.05% 212
2023
Q4 		$249K Buy
4,159
+534
+15% +$37.6K 0.06% 223
2023
Q3 		$285K Sell
3,625
-210
-5% -$17.1K 0.08% 175
2023
Q2 		$287K Sell
3,835
-509
-12% -$43.7K 0.08% 183
2023
Q1 		$438K Sell
4,344
-1,331
-23% -$114K 0.14% 75
2022
Q4 		$291K Sell
5,675
-1,287
-18% -$71.2K 0.08% 196
2022
Q3 		$380K Buy
6,962
+2,242
+48% +$132K 0.1% 189
2022
Q2 		$242K Buy
4,720
+2,098
+80% +$126K 0.07% 134
2022
Q1 		$148K Buy
+2,622
New +$159K 0.02% 179

Other funds holding QNTM

PTP
Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
AUB
Atlantic Union Bankshares Glen Allen, Virginia $5.21B AUM 19.46% 1-Year Est. Return

AdvisorShares Investments's QNTM Position: Q1 2026 in Review

AdvisorShares Investments increased its Quantum Biopharma Class B Subordinate Voting Shares (QNTM) stake by 119% in Q1 2026, buying an estimated $266K and bringing the position to 108,591 shares worth $524K. The position accounts for 0.1% of the portfolio, ranked #123.

AdvisorShares Investments first reported a position in QNTM in Q1 2022 and has held it in 17 quarters since. The position peaked at $749K in Q2 2025. 25 funds tracked by Wall St. Rank hold QNTM as of Q1 2026.

  • AdvisorShares Investments held 108,591 shares of Quantum Biopharma Class B Subordinate Voting Shares worth $524K as of Q1 2026.
  • AdvisorShares Investments bought 58,958 Quantum Biopharma Class B Subordinate Voting Shares shares in Q1 2026, an estimated $266K.
  • Quantum Biopharma Class B Subordinate Voting Shares made up 0.1% of AdvisorShares Investments's portfolio in Q1 2026, its #123 holding.
  • AdvisorShares Investments first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q1 2022 and has held it in 17 quarters since.
  • AdvisorShares Investments's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $749K in Q2 2025.
  • 25 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q1 2026.

Based on AdvisorShares Investments's 13F filing for Q1 2026, filed 28 Apr 2026.